You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 7, 2024

Details for Patent: 5,602,162


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,602,162
Title: Imidazole, triazole and tetrazole derivatives
Abstract:A class of substituted imidazole, triazole and tetrazole derivatives are selective agonists of 5-HT.sub.1 -like receptors and are therefore useful in the treatment of clinical conditions, in particular migraine and associated disorders, for which a selective agonist of these receptors is indicated.
Inventor(s): Baker; Raymond (Much Hadham, GB2), Matassa; Victor G. (Furneux Pelham, GB2), Street; Leslie J. (Harlow, GB2)
Assignee: Merck, Sharp & Dohme Ltd. (Hoddesdon, GB2)
Application Number:08/438,621
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,602,162

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,602,162

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9102222Feb 01, 1991
United Kingdom9106917Apr 03, 1991
United Kingdom9113415Jun 21, 1991
United Kingdom9122451Oct 23, 1991

International Family Members for US Patent 5,602,162

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0497512 ⤷  Sign Up 98C0037 France ⤷  Sign Up
European Patent Office 0497512 ⤷  Sign Up C980019 Netherlands ⤷  Sign Up
European Patent Office 0497512 ⤷  Sign Up SPC/GB98/035 United Kingdom ⤷  Sign Up
European Patent Office 0497512 ⤷  Sign Up 9891028-4 Sweden ⤷  Sign Up
European Patent Office 0497512 ⤷  Sign Up 99C0011 Belgium ⤷  Sign Up
European Patent Office 0497512 ⤷  Sign Up 28/1998 Austria ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.